ISPOR - Richard Idro

HTA20 HEALTH ECONOMIC EVALUATION MODEL FOR BREAST CANCER RISK MANAGEMENT THROUGH PREIMPLANTATION GENETIC TESTING FOR MONOGENIC DISORDERS (PGT-M) IN BRCA1/2 PATHOGENIC VARIANT CARRIERS

Oct 1, 2026, 00:00

HTA20 HEALTH ECONOMIC EVALUATION MODEL FOR BREAST CANCER RISK MANAGEMENT THROUGH PREIMPLANTATION GENETIC TESTING FOR MONOGENIC DISORDERS (PGT-M) IN BRCA1/2 PATHOGENIC VARIANT CARRIERS

Oct 1, 2026, 00:00

Richard Idro

Jul 17, 2025, 13:54 PM

First Name : Richard

Last Name : Idro

Degrees : MD, PhD

HTA20 HEALTH ECONOMIC EVALUATION MODEL FOR BREAST CANCER RISK MANAGEMENT THROUGH PREIMPLANTATION GENETIC TESTING FOR MONOGENIC DISORDERS (PGT-M) IN BRCA1/2 PATHOGENIC VARIANT CARRIERS

Oct 1, 2026, 00:00

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now